Analysis of clinical experience of autologous mononuclear bone marrow cells CMBMCJ and fetal cells iFC) use in combination with surgical methods of treatment in patients ischemic cardiomyopathy was made. A year of prospective follow-up period showed that methods of stem cells introduction are safe and well-tolerated by patients. Positive effect of the intervention performed on the course of coronary and heart insufficiency was noticed. Ultrasonic examination showed that improved values of intracardiac hemodynamic was noticed only in the patients after treatment with fetal cells in comparison with the control group of patients and with the group of patients treated with MBMC.